AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 22336748
Drug: No Treatment
RxNorm normalized name: NO
DrugBank: Nitric Oxide (DB00435)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: No Treatment Control (NTC)
Trial: 26297323
Drug: Experimental treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Experimental treatment (automated texting smoking intervention)
Trial: 26678710
Drug: Intravenous paracetamol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous paracetamol (1g every 4 hours for 72 hours)
Trial: 24633277
Drug: 24-hour antibiotic
RxNorm normalized name: Antibiotics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 24-hour antibiotic regimen (Ampicillin/Cloxacillin and Metronidazole)
Trial: 24633277
Drug: 7-day antibiotic
RxNorm normalized name: Antibiotics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7-day antibiotic regimen (Ampicillin/Cloxacillin and Metronidazole)
Trial: 24633277
Drug: Cost of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cost of antibiotics for short term prophylaxis
Trial: 24633277
Drug: Cost of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cost of antibiotics for long term prophylaxis
Trial: 21920501
Drug: Cognitive-behavioural therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavioural therapy for pathological gambling plus a standard drug therapy for schizophrenia
Trial: 21920501
Drug: Standard drug
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard drug therapy for schizophrenia
Trial: 18333946
Drug: pH-balanced gel
RxNorm normalized name: acetic acid / oxyquinoline Vaginal Gel [Fem pH]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: pH-balanced gel (pH 3.8-4.2) with regular size, non-applicator tampons
Trial: 18333946
Drug: Existing lubricating
RxNorm normalized name: Eyes Alive Lubricating
DrugBank: Carboxymethylcellulose (DB11059)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Existing lubricating gel (pH 5.1) with regular size, non-applicator tampons
Trial: 24692816
Drug: Amlodipine (5-10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amlodipine (5-10 mg/d)
Trial: 15860521
Drug: Perindopril 8
RxNorm normalized name: perindopril 8 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perindopril 8 mg once daily
Trial: 9528197
Drug: Clarithromycin (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clarithromycin (500 mg thrice daily for 14 days) + omeprazole (twice daily for 20 days and once for one month) + metronidazole (500 mg twice daily for 10 days)
Trial: 9528197
Drug: Amoxycillin (twice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxycillin (twice daily for 14 days) + omeprazole (twice daily for 20 days and once for one month) + metronidazole (500 mg twice daily for 10 days)
Trial: 9528197
Drug: Azithromycin (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azithromycin (500 mg once daily for 6 days) + omeprazole (twice daily for 20 days and once for one month) + metronidazole (500 mg twice daily for 10 days)
Trial: 7930131
Drug: Oral Temperature
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral Temperature (OT)
Trial: 7930131
Drug: Rectal Temperature
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rectal Temperature (RT)
Trial: 3219156
Drug: KW-3049 (benidipine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: KW-3049 (benidipine hydrochloride) 2 x 8 mg
Trial: 3219156
Drug: Nifedipine 2
RxNorm normalized name: nifedipine 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine 2 x 10 mg
Trial: 29325517
Drug: The Daily
RxNorm normalized name: TITANIUM DIOXIDE 0.036 g in 1 mL / ZINC OXIDE 0.0234 g in 1 mL TOPICAL LOTION [SOOTHE Daily Mineral Sunscreen]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: The Daily Mile (15 minutes of running or walking integrated into the school day for 12 months)
Trial: 29325517
Drug: The Daily
RxNorm normalized name: TITANIUM DIOXIDE 0.036 g in 1 mL / ZINC OXIDE 0.0234 g in 1 mL TOPICAL LOTION [SOOTHE Daily Mineral Sunscreen]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: The Daily Mile
Trial: 30280946
Drug: CE 0.45
RxNorm normalized name: Femtrace 0.45mg Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CE 0.45 mg/MPA 1.5 mg
Trial: 22325086
Drug: Valsartan add-on
RxNorm normalized name: Valsartan
DrugBank: Valsartan (DB00177)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Valsartan add-on treatment
Trial: 21436597
Drug: Non-ARB treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-ARB treatment (Control)
Trial: 19159566
Drug: Drug-resistant regimen
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug-resistant regimen (3RFT AM Ofx Pto PAS-INH/5RFT Ofx Pto PAS-INH)
Trial: 19159566
Drug: MDR-TB patients
RxNorm normalized name: patent blue violet
DrugBank: Patent Blue (DB13967)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MDR-TB patients on drug-resistant regimen
Trial: 19159566
Drug: Drug-resistant regimen
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug-resistant regimen
Trial: 8837903
Drug: Moclobemide 400
RxNorm normalized name: moclobemide
DrugBank: Moclobemide (DB01171)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moclobemide 400 mg daily
Trial: 7908356
Drug: Immediate zidovudine
RxNorm normalized name: Zidovudine
DrugBank: Zidovudine (DB00495)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Immediate zidovudine (250 mg four times daily)
Trial: 3067330
Drug: Colloidal bismuth
RxNorm normalized name: Colloidal bismuth subcitrate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Colloidal bismuth subcitrate (De‐Nol) 300 mg four times daily with ASA
Trial: 3067330
Drug: Aspirin (ASA)
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin (ASA) 2.5 g plus placebo
Trial: 29288911
Drug: Perampanel monotherapy
RxNorm normalized name: Perampanel
DrugBank: Perampanel (DB08883)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Perampanel monotherapy
Trial: 29404725
Drug: Tocilizumab 8
RxNorm normalized name: tocilizumab 80 MG in 4 ML Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tocilizumab 8 mg + MTX
Trial: 29404725
Drug: Tocilizumab 8
RxNorm normalized name: tocilizumab 80 MG in 4 ML Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tocilizumab 8 mg
Trial: 29483080
Drug: Sirukumab 100
RxNorm normalized name: Sirukumab
DrugBank: Sirukumab (DB11803)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sirukumab 100 mg
Trial: 29404725
Drug: Tocilizumab 4
RxNorm normalized name: tocilizumab 400 MG in 20 ML Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tocilizumab 4 mg + MTX
Trial: 29404725
Drug: Sirukumab 100
RxNorm normalized name: Sirukumab
DrugBank: Sirukumab (DB11803)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sirukumab 100 mg + MTX
Trial: 29404725
Drug: Sirukumab 50
RxNorm normalized name: Sirukumab
DrugBank: Sirukumab (DB11803)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sirukumab 50 mg + MTX
Trial: 29483080
Drug: Sirukumab 50
RxNorm normalized name: Sirukumab
DrugBank: Sirukumab (DB11803)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sirukumab 50 mg
Trial: 29404725
Drug: Tocilizumab 8
RxNorm normalized name: tocilizumab 80 MG in 4 ML Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tocilizumab 8 mg + MTX, Sirukumab 100 mg + MTX, Sarilumab 200 mg + MTX
Trial: 28490337
Drug: Conventional antidiabetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional antidiabetic treatment
Trial: 28490337
Drug: Sitagliptin and
RxNorm normalized name: sitagliptin and simvastatin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sitagliptin and Conventional treatment
Trial: 20214441
Drug: Amoxicillin-metronidazole combination
RxNorm normalized name: Metronidazole
DrugBank: Metronidazole (DB00916)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amoxicillin-metronidazole combination and scaling and root planing
Trial: 16388496
Drug: History of
RxNorm normalized name: BEMOTRIZINOL 0.8 mL in 100 mL / OCTINOXATE 7 mL in 100 mL TOPICAL CREAM [THE HISTORY OF WHOO GONG JIN HYANG HAE YOON SUN]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: History of injections or STIs
Trial: 14647223
Drug: 5 g
RxNorm normalized name: 15 g/31 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 g recombinant human lactoferrin
Trial: 9051165
Drug: Electro-acupuncture (EA)
RxNorm normalized name: ELECTRODE SPRAY,ELECTRO MIST
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Electro-acupuncture (EA) at Zusanli (St. 36), Sanyinjiao (Sp. 6), Hegu (L.I.4), and Neiguan (P.6) points
Trial: 9051165
Drug: Epidural morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural morphine (1 mg)
Trial: 31267698
Drug: ELISA-positive participants
RxNorm normalized name: pseudopterogorgia elisabethae extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ELISA-positive participants (GADA ≥ 5 U/mL)
Trial: 31267698
Drug: ELISA-negative participants
RxNorm normalized name: pseudopterogorgia elisabethae extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ELISA-negative participants (GADA < 5 U/mL)
Trial: 17336171
Drug: Antenatal screening
RxNorm normalized name: SUN PROTECTANTS/SCREENS,TOPICAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antenatal screening and treatment of mothers with penicillin
Trial: 17336171
Drug: Point-of-care decentralized
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Point-of-care decentralized screening and treatment
Trial: 10205213
Drug: 0.2% GTN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2% GTN three times daily
Trial: 10205213
Drug: Escalating dose
RxNorm normalized name: peanut allergenic extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Escalating dose GTN starting at 0.2% with weekly 0.1% increments to a maximum of 0.6%
Trial: 31663855
Drug: Blended CBT
RxNorm normalized name: Io-Blend
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Blended CBT (10 weekly face-to-face sessions and 9 web-based sessions)
Trial: 31663855
Drug: Standard CBT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard CBT (15 to 20 weekly face-to-face sessions)
Trial: 28556432
Drug: One-piece dental
RxNorm normalized name: Gel-One
FDA approved: no
EMA approved: no
PMDA approved: no
Description: One-piece dental implants (S1)
Trial: 28556432
Drug: Two-piece dental
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two-piece dental implants (S2)
Trial: 21411512
Drug: Low-dose recombinant
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose recombinant methionyl human leptin (30 mg/day)
Trial: 21411512
Drug: High-dose recombinant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose recombinant methionyl human leptin (80 mg/day)
Trial: 18923838
Drug: Rheopheresis (two
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rheopheresis (two treatments, each lasting about 2 hours, within 3 days)
Trial: 18923838
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (i.v. corticosteroids: methylprednisolon 250 mg for 3 days and tapering to zero, or i.v. hemodilution: 500 mL 6% hydroxyethyl starch plus 600 mg pentoxifylline per day for 10 days)
Trial: 16583215
Drug: Gd-DTPA contrast
RxNorm normalized name: Gd-EOB-DTPA
DrugBank: Gadoxetic acid (DB08884)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gd-DTPA contrast agent during bolus administration
Trial: 3629090
Drug: 0.5 mg
RxNorm normalized name: biotin 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg arecoline
Trial: 3549875
Drug: 0.2 mg
RxNorm normalized name: niacin 0.2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2 mg glycopyrrolate
Trial: 29324401
Drug: Controlled-release carbamazepine
RxNorm normalized name: carbamazepine Extended Release Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Controlled-release carbamazepine monotherapy (CBZ-CR)
Trial: 29324401
Drug: Lamotrigine and
RxNorm normalized name: Lamotrigine
DrugBank: Lamotrigine (DB00555)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lamotrigine and valproate combination therapy (LTG+VPA)
Trial: 21254378
Drug: Initial lumbar
RxNorm normalized name: brigatinib
DrugBank: Brigatinib (DB12267)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Initial lumbar puncture on day 8 in remission induction therapy
Trial: 20354750
Drug: Zoledronic acid
RxNorm normalized name: Zoledronic Acid
DrugBank: Zoledronic acid (DB00399)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Zoledronic acid (4 mg intravenous monthly for 6 months)
Trial: 18048433
Drug: Prednisolone (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisolone (60 mg/day for 1 week)
Trial: 27922020
Drug: Losartan 50
RxNorm normalized name: LOSARTAN 50MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losartan 50 mg every other day (EOD), once a morning (OM)
Trial: 27922020
Drug: Standard antihypertensive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard antihypertensive pharmacotherapy
Trial: 23807278
Drug: 12 ml
RxNorm normalized name: syringe, disposable, 12 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12 ml of 0.5 % bupivacaine plus 150 mg magnesium sulphate (in 3 ml 0.9 % saline)
Trial: 6428120
Drug: Insulin +
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin + glibenclamide
Trial: 6428120
Drug: Insulin +
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin + placebo
Trial: 6972513
Drug: Hydrocortisone (12.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrocortisone (12.5 mg/kg, two doses on the first day of life)
Trial: 29093180
Drug: Rozanolixizumab (IV
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rozanolixizumab (IV or SC) at doses of 1, 4, or 7 mg/kg
Trial: 29093180
Drug: Rozanolixizumab (highest-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rozanolixizumab (highest-dose IV group)
Trial: 25870986
Drug: ART12 (12
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ART12 (12 weeks of antiretroviral therapy)
Trial: 25870986
Drug: ART48 (48
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ART48 (48 weeks of antiretroviral therapy)
Trial: 15012784
Drug: No pancreatic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No pancreatic enzyme replacement therapy (no PERT)
Trial: 31811682
Drug: All-trans retinoic
RxNorm normalized name: all trans Retinoic acid
DrugBank: Tretinoin (DB00755)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All-trans retinoic acid (ATRA) treatment
Trial: 9601155
Drug: Proctoclysis (rectal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Proctoclysis (rectal hydration) with normal saline or tap water at a rate of 250 +/- 63 cc/hr for 15 +/- 8 days
Trial: 30702488
Drug: Rebamipide (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rebamipide (100 mg) plus Lansoprazole (30 mg daily)
Trial: 30702488
Drug: Placebo plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo plus Lansoprazole (30 mg daily)
Trial: 25525195
Drug: 600 mg
RxNorm normalized name: mesna 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mg of darunavir (DRV600) once daily
Trial: 25525195
Drug: 800 mg
RxNorm normalized name: bran 800 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 800 mg of darunavir (DRV800) once daily
Trial: 21729811
Drug: Lidocaine 0.5
RxNorm normalized name: LIDOCAINE 0.5% GEL,TOP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine 0.5 mg/kg (Group L)
Trial: 21729811
Drug: Lidocaine 0.5
RxNorm normalized name: LIDOCAINE 0.5% GEL,TOP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine 0.5 mg/kg‐ephedrine 30 μg/kg (Group LE)
Trial: 21729811
Drug: Ephedrine 30
RxNorm normalized name: ephedrine 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ephedrine 30 μg/kg (Group E30)
Trial: 21729811
Drug: Ephedrine 70
RxNorm normalized name: guaifenesin-pseudoephedrine 700 mg-80 mg oral tablet, extended release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ephedrine 70 μg/kg (Group E70)
Trial: 17121171
Drug: Sertraline 50
RxNorm normalized name: sertraline 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sertraline 50 mg for 4 weeks followed by sertraline 50 mg to 100 mg for 2 weeks for nonresponders
Trial: 15371138
Drug: Interferon-based therapies
RxNorm normalized name: interferon-beta
DrugBank: Human interferon beta (DB14999)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon-based therapies
Trial: 10217581
Drug: 1.2 mg
RxNorm normalized name: RNA 1.2 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.2 mg of alum-precipitated mAb 13B8.2
Trial: 7618705
Drug: Esmolol (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Esmolol (300 micrograms.kg‐1.min‐1 during CPB after bolus of 2 mg/kg prior to CPB)
Trial: 18549515
Drug: Active rehabilitation
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active rehabilitation (group R) - 10 sessions including exercises on a stabilometric platform, point de mire, and a series of five exercises repeated five times daily.
Trial: 18549515
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (group C) - told to 'perform their daily activities'.
Trial: 14756468
Drug: Fexofenadine 60
RxNorm normalized name: fexofenadine 60 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fexofenadine 60 mg and pseudoephedrine 120 mg twice daily for 2 weeks
Trial: 14756468
Drug: Loratadine 10
RxNorm normalized name: loratadine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Loratadine 10 mg and montelukast 10 mg once daily for 2 weeks
Trial: 11294481
Drug: Sertraline (50-150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sertraline (50-150 mg for nortriptyline comparator trial; 50-100 mg for fluoxetine comparator trial)
Trial: 9021962
Drug: Interferon alfa-n3
RxNorm normalized name: Interferon alfa-n3
DrugBank: Interferon alfa-n3 (DB00018)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon alfa-n3 lower doses (1.0, 2.5, 5.0 MU)
Trial: 29370144
Drug: Whey Proteins
RxNorm normalized name: whey protein hydrolysate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Whey Proteins (WP) pre-meal (20 g)
Trial: 25514542
Drug: MPH-MLR 80
RxNorm normalized name: MPH
DrugBank: Methylphenidate (DB00422)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: MPH-MLR 80 mg capsule or sprinkles
Trial: 25514542
Drug: Ritalin IR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ritalin IR 25 mg
Trial: 15570920
Drug: CPT-11 with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CPT-11 with CDDP therapy
Trial: 10772604
Drug: 50 mg/day
RxNorm normalized name: infigratinib phosphate 50 mg/day (25 mg x 2) ORAL CAPSULE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg/day naltrexone
Trial: 9310275
Drug: Bisoprolol once
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bisoprolol once daily for 8 weeks
Trial: 9310275
Drug: Nifedipine retard
RxNorm normalized name: Nifedipine
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nifedipine retard twice daily for 8 weeks
Trial: 17852760
Drug: Cognitive rehabilitation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive rehabilitation treatment (25 hours, across 8 weeks)
Trial: 26849844
Drug: Duloxetine (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Duloxetine (60 mg/day)
Trial: 7502516
Drug: ACE-inhibitor Cilacapril,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACE-inhibitor Cilacapril, taken once a day between 7.00 a.m. and 9.00 a.m.
Trial: 1953094
Drug: Glutamine-enriched intravenous
RxNorm normalized name: Glutamine
DrugBank: L-Glutamine (DB00130)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Glutamine-enriched intravenous feedings (0.57 g/kg/day, GLN)
Trial: 1953094
Drug: Standard parenteral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard parenteral nutrition (STD)
Trial: 7010893
Drug: Heparin, 5000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin, 5000 units every 8 hours for 14 days
Trial: 7010893
Drug: Placebo administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo administered as soon as possible after the fracture
Trial: 28610932
Drug: Manual disinfection
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Manual disinfection with 0.5% sodium hypochlorite solution
Trial: 23393182
Drug: Insulin-resistant individuals
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin-resistant individuals
Trial: 23393182
Drug: Insulin-sensitive individuals
RxNorm normalized name: Fluorimax Sensitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin-sensitive individuals
Trial: 21542027
Drug: 0.2 g/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2 g/kg dose of alcohol (cumulative dose 0.8 g/kg)
Trial: 9260367
Drug: Felodipine ER
RxNorm normalized name: Felodipine ER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Felodipine ER (5-10 mg daily, doubled if necessary)
Trial: 9260367
Drug: Atenolol (50-100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atenolol (50-100 mg daily, doubled if necessary)
Trial: 8294169
Drug: Netilmicin (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Netilmicin (100 mg dose)
Trial: 2832287
Drug: Cyproheptadine (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyproheptadine (0.1 mg/kg body weight)
Trial: 29943054
Drug: Laparoscopic-guided TAP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Laparoscopic-guided TAP block with 20 ml of 0.25% bupivacaine
Trial: 29943054
Drug: Standard port
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard port site infiltration with 3-5 ml of 0.25% bupivacaine
Trial: 27994001
Drug: 400 μg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 μg folic acid/day for 90 days